Literature DB >> 9834089

Efficient presentation of multivalent antigens targeted to various cell surface molecules of dendritic cells and surface Ig of antigen-specific B cells.

K Serre1, P Machy, J C Grivel, G Jolly, N Brun, J Barbet, L Leserman.   

Abstract

To study the relation between the form of an Ag and the response to it, we compared presentation in vitro with hen egg lysozyme (HEL)-specific T cells from TCR transgenic mice of free HEL and liposome-encapsulated HEL by different APC. HEL-specific splenic B cells or bone marrow-derived dendritic cells were incubated with free HEL or HEL-containing liposomes targeted by Ab to either surface Ig, the Fc receptor, or MHC class I and II molecules. Ag presentation by HEL-specific B cells was at least 100-fold more efficient for HEL in surface Ig-targeted liposomes than free HEL taken up by the same receptor or HEL in liposomes targeted to class I or II molecules. Ag presentation by dendritic cells from Fc receptor-targeted vesicles was augmented 1,000-10,000-fold compared with free Ag or nontargeted liposomes, but presentation was also efficient when Ag was targeted to class I or II molecules. These results indicate that Ag-specific B cells and dendritic cells can be equally efficient in stimulating IL-2 production by Ag-specific T cells from unimmunized TCR transgenic mice when the Ag is multivalent and taken up by appropriate receptors. In contrast to B cells, which require engagement of surface Ig for optimal presentation, dendritic cells may present Ag by means of several different cell surface molecules.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9834089

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens.

Authors:  Douglas S Watson; Aaron N Endsley; Leaf Huang
Journal:  Vaccine       Date:  2012-02-02       Impact factor: 3.641

2.  Human dendritic cells are superior to B cells at presenting a major histocompatibility complex class II-restricted heterologous antigen expressed on recombinant Streptococcus gordonii.

Authors:  S Corinti; D Medaglini; C Prezzi; A Cavani; G Pozzi; G Girolomoni
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

Review 3.  Recent advancements in cytotoxic T lymphocyte generation methods using carbohydrate-coated liposomes.

Authors:  Yuzuru Ikehara; Masahiro Yamanaka; Takashi Yamaguchi
Journal:  J Biomed Biotechnol       Date:  2010-06-17

4.  Liposomal meningococcal B vaccination: role of dendritic cell targeting in the development of a protective immune response.

Authors:  Carmen Arigita; Lisette Bevaart; Linda A Everse; Gerben A Koning; Wim E Hennink; Daan J A Crommelin; Jan G J van de Winkel; Martine J van Vugt; Gideon F A Kersten; Wim Jiskoot
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

5.  Combination use of immune complexes and a Ca2(+) channel blocker azelnidipine enhances interleukin-12 p40 secretion without T helper type 17 cytokine secretion in human monocyte-derived dendritic cells.

Authors:  T Abe; I Fuse; M Narita; M Takahashi; Y Aizawa
Journal:  Clin Exp Immunol       Date:  2009-06       Impact factor: 4.330

6.  Specific targeting of whole lymphoma cells to dendritic cells ex vivo provides a potent antitumor vaccine.

Authors:  Christian Adam; Josef Mysliwietz; Ralph Mocikat
Journal:  J Transl Med       Date:  2007-03-14       Impact factor: 5.531

7.  Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics.

Authors:  Elias J Sayour; Luis Sanchez-Perez; Catherine Flores; Duane A Mitchell
Journal:  J Immunother Cancer       Date:  2015-04-21       Impact factor: 13.751

8.  Tumor-derived autophagosomes (DRibbles) induce B cell activation in a TLR2-MyD88 dependent manner.

Authors:  Weixia Li; Meng Zhou; Hongyan Ren; Hong-Ming Hu; Liwei Lu; Meng Cao; Li-xin Wang
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

9.  Adjuvant effect of cationic liposomes for subunit influenza vaccine: influence of antigen loading method, cholesterol and immune modulators.

Authors:  Christophe Barnier-Quer; Abdelrahman Elsharkawy; Stefan Romeijn; Alexander Kros; Wim Jiskoot
Journal:  Pharmaceutics       Date:  2013-07-25       Impact factor: 6.321

10.  Pulmonary Delivery of Virosome-Bound Antigen Enhances Antigen-Specific CD4+ T Cell Proliferation Compared to Liposome-Bound or Soluble Antigen.

Authors:  Rebecca A M Blom; Mario Amacker; R Maarten van Dijk; Christian Moser; Philip A Stumbles; Fabian Blank; Christophe von Garnier
Journal:  Front Immunol       Date:  2017-04-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.